|
Adrenal
catecholamine
concentrations in pheochromocytoma, 299
congenital adrenal hyperplasia and urinary symptoms, 290
laparoscopic adrenalectomy in pheochromocytoma, 299
Bladder
BCG
vs. chemotherapy for carcinoma in situ, 507
bladder calculi and urethral duplication, 259
bladder cancer, superficial, 204
bladder instillations of doxorubicin, 204
bladder neoplasms, 204
bladder outlet obstruction, experimental, 579
bladder replacement, augmentation - acellular grafts, 198
calculous, 472
disease specific survival curves, transitional cell carcinoma, 208
effect of fluid intake on urinary symptoms in women, 610
G1Ta bladder cancer - surveillance schedule, 179
ileal neobladder, laparoscopic, 214
intermittent bladder urinary retention, 259
intravesical wire as foreign body, 472
laparoscopic assisted cystoprostatectomy and ileal bladder, 362
laparoscopic assisted radical cystectomy, 214
laparoscopic radical cystoprostatectomy with bilateral nephroureterectomy,
592
long-term follow-up, transitional cell carcinoma, 204
lymphadenectomy with cystectomy, laparoscopic, 214
orthotopic ureterocele masquerading a bladder tumor, 549
overall survival curves, transitional cell carcinoma, 209
recurrence, transitional cell carcinoma, 206
structural alterations of the bladder caused by experimental instability,
579
transitional cell carcinoma, 204
treatment delay and prognosis in invasive bladder cancer, 609
Children
balanitis
xerotica obliterans in boys, 511
bladder decompensation in boys with posterior urethral valves, 412
congenital adrenal hyperplasia and urinary symptoms, 290
congenital anomalies, 57
cryptorchidism, 57
cryptorchidism and hCG, 562
cystourethrogram in children with vesicoureteral reflux, 91
diagnosis of pediatric urolithiasis, 510
duplicated collecting system, 157
dysfunctional elimination syndrome, 291
dysfunctional voiding and incontinence scoring system, 184
graft survival in children, 558
hCG vs. collagen and seminiferous analysis in cryptorchidism, 562
inguinal hernia, 57
kidney transplantation in children, 558
laparoscopy in intersex patients, 282
morphometric analysis in cryptorchidism, 562
minimally invasive pediatric nephrectomy, 273
multicystic dysplastic kidney, 411
multimodal approach of treating bladder-prostate rhabdomyosarcoma,
613
neurogenic bladder and urofacial syndrome, 477
phimosis and topical steroids, 370
pre-pubertal testicular dermoid cyst, 359
renal failure and urofacial syndrome, 477
seminiferous tubules in cryptorchidism, 562
simplified upper pole nephrectomy in children, 157
SIS bladder neck slings for incontinence associated with neuropathic
bladder, 614
spastic neurogenic bladder and urofacial syndrome, 477
stapleless laparoscopic cystectomy, 214
subureteral injection of deflux for reflux, 183
surgery for cryptorchidism, 57
testicular stereology in cryptorchidism, 562
topical treatment of phimosis and foreskin anatomy, 370
ureterocele, 157
ureteroscopy for pediatric urolithiasis, 92
urinary diversion, laparoscopic, 214
urofacial syndrome, 477
Endourology
and Laparoscopy
atrial
migration of nephrostomy catheter, 470
ESWL for acute renal colic, 163
ESWL in morbidly obese patients, 105
evolution of hand-assisted laparoscopic surgery, 164
hand-assisted laparoscopic nephrectomy in large kidneys, 526
indications for percutaneous nephrostomy for patients with obstruction,
117
kidney displacement simulator for retroperitoneal laparoscopic nephrectomy,
593
laparoscopic assisted cystoprostatectomy and ileal bladder, 362
laparoscopic adrenalectomy in pheochromocytoma, 299
laparoscopic live donor nephrectomy, 17, 421
laparoscopic nephrectomy at a community hospital, 73
laparoscopic nephrectomy in infectious disease, 526
laparoscopic partial nephrectomy for cancer, 73
laparoscopic radical prostatectomy, 165, 228
laparoscopic rectovesical fistula repair, 393
laparoscopic skills training using a webcam trainer, 74
laparoscopy for refluxing segmental ureter, 356
laparoscopy for treatment of incisional lumbar hernia, 309
laparoscopy in renal and ureteral stones, 111
outpatient laparoscopic pyeloplasty, 394
percutaneous lithotripsy for staghorn stones, 71
percutaneous nephrolithotomy for caliceal diverticular calculi,
162
percutaneous nephrostomy, 470
retroperitoneoscopy for renal and ureteral stones, 111
retroperitoneoscopy with extracorporeal ureteral anastomosis, 147
serum catecholamine in laparoscopic adrenalectomy for pheochromocytoma,
299
transperitoneal approach for partial nephrectomy, 100
ureteral double-J stenting, 431
Y-shaped orthotopic ileal bladder by laparoscopy, 362
Erectile
dysfunction and Ejaculation
antihypertensive
drugs, 342
erectile dysfunction after long-distance cycling event, 497
hypertension and sildenafil, 342
IIEF, 452
in spinal cord trauma, 376
pelvic floor exercises for erectile dysfunction, 403
sexual function following vasectomy, 452
sildenafil and multiple antihypertensive drugs, 342
vasectomy and sexual function, 452
Genetics
cariotype
and varicocele infertility, 241
HSP90 polymorphism, 241
kidney cancer and XP11.2 translocation, 252
TFE3 protein, human, 251
von Recklinghausen’s disease and urogenital manifestations,
153
Y-chromosome microdelection, 241
Hormones
FSH
and non-obstructive azoospermia, 44
FSH, LH and varicocele infertility, 241
testosterone level and varicocele infertility, 241
Imaging
combined
PET/CT imaging, 274
CT in symptomatic and incidental pheochromocytoma, 496
CT urography of urinary diversions, 520
extended technique for prostate biopsy, 395
findings of segmental testicular infarction, 275
MDCT angiography in living laparoscopic renal donors, 167
MDCT urography of upper tract urothelial neoplasms, 397
MR spectroscopy and Gleason score, 166
MRI of prostate cancer at 1.5 and 3.0 T, 594
pain during transrectal ultrasound guided prostate biopsy, 595
prostate biopsy directed with endorectal MR spectroscopic imaging,
494
pseudocapsule in MRI and renal neoplasm, 75
Impotence:
see Erectile dysfunction
Incontinence
completely
dry rate: a critical re-evaluation of the outcomes of slings, 612
effect of fluid intake on urinary symptoms in women, 610
groin pain after TVT or similar suburethral sling, 288
in postmenopausal women treated with raloxifene or estrogen, 182
Portuguese version of ICIQ-SF, 482
preoperative pressure-flow studies and continence surgery, 88
quality of life questionnaire, 482
sexual function and organ prolapse, 409
stress urinary incontinence, 482
vaginal erosion after transobturator suburethral tape, 289
Infections
laparoscopic
nephrectomy in infectious disease, 526
pyelonephritis and laparoscopic nephrectomy, 22
pyonephrosis, 22
Infertility
assisted
ejaculation in spinal cord trauma, 377
azoospermia, 338
azoospermia and varicocele, 541
genetic polymorphism and infertility, 236
FSH and non-obstructive azoospermia, 44
heat shock protein 90 and varicocele infertility, 236
investigation of non-obstructive azoospermia, 44
intracytoplasmic sperm injection (ICSI), 42
male infertility in spinal cord trauma, 375
non-obstructive azoospermic patients, 338
sperm quality in spinal cord trauma, 379
spermatogenesis after varicocele repair, 541
spermatozoa and spermatids in azoospermic men, 42
testicular histology vs. azoospermia vs. varicocele, 541
testicular histopathological diagnosis for ICSI, 338
Investigative
urology
anatomical
risks of transobturator suburethral tape, 505
apoptosis and proliferation in human undescended testes, 404
bladder outlet obstruction, experimental, 579
calcium channel blocker and renal mitochondrial function, 384
continent gastrostomy, 62
detrusor instability, experimental, 579
estrogen effect on voiding in the male mouse, 503
GAG in human penis and albuginea, 83
maternal undernutrition and glomeruli number in rats, 84
Macedo-Malone antegrade enema, 173
Monti principle, 62
pelvic floor exercises for erectile dysfunction, 403
structural alterations of the bladder caused by instability, 579
urinary GAG excretion during normal cycle in women, 174
urinary reservoirs, 62
warm renal ischemia, 384
Kidney
cancer: see Renal neoplasms
Kidney
transplantation: see Renal transplantation
Lithiasis
calcium,
3
calcium oxalate, 6
calcium oxalate mono and di-hydrate, 6
calcium phosphate, 6
caliceal diverticular calculi, 162
comparison of 3 generations of lithotripters, 271
corticosteroids with tamsulosin medical expulsive therapy for lithiasis,
591
cystine, 6
densitometry, 3
ESWL at 60 or 120 shocks per minute, 391
ESWL for acute renal colic, 163
ESWL in morbidly obese patients, 105
extracorporeal shock wave lithotripsy, 3
follow-up studies, 29
gender, 31
jejunoileal bypass reversal effect on stone formation, 590
lithotripters for SWL in morbidly obese patients, 109
lower pole calculi and ESWL, 392
management of staghorn calculi guidelines, 271
metabolic evaluation, 29
obesity and kidney stones, 70
open surgery, 71
pelvicaliceal stones, 105
percutaneous lithotripsy for staghorn stones, 71
retroperitoneoscopy for renal and ureteral stones, 111
risk factors, 29, 70
stone radiodensity and outcome of SWL, 3
struvite, 6
tamsulosin increases success rate of single ESWL for renal stones,
492
treatment outcome after SWL, 3
ureteral access sheath and stone-free rates, 493
uric acid, 6
weight gain and kidney stones, 70
Pathology
age
vs. outcome vs. clinicopathologic findings in radical prostatectomy,
534
classification of urothelial neoplasms, 505
current practice of Gleason grading among pathologists, 172
Gleason grades 3 and 4, clinical outcomes, 81
high-grade PIN and re-biopsy, 171
patient and urologist driven second opinion of prostate needle biopsies,
600
PIN and glandular atypia, 80
prognostic and predictive factors in needle biopsy of the prostate,
400
prognostic factors in radical prostatectomy and lymphadenectomy
specimens, 401
propionibacterium acnes and prostate cancer, 500
PSA levels and needle biopsy findings, 502
urothelial neoplasms in patients 20 years or younger, 599
Pelvis
orthotopic
ureterocele masquerading a bladder tumor, 549
pelvic neoplams and ureteral obstruction, 117
uretero-vaginal fistula, 264
von Recklinghausen’s disease and urogenital manifestations,
153
Penis
deep-seated
sarcomas, 245
degloving of penile skin, 262
GAG in human penis, 83
human superoxide dismutase for Peyronie’s disease, 602
malignant fibrohistiocytoma, 247
neoplasm metastasis, 245
nerves to the male human urethra, 603
Peyronie’s disease, acellular matrix grafts, 198
phimosis and topical steroids, 370
topical treatment of phimosis and foreskin anatomy, 370
total penectomy, 245
traumatic degloving of penile skin, 262
|
|
Prostate
cancer
age
and pathological features in PCa, 331, 534
age vs. outcome vs. clinicopathologic findings in radical prostatectomy,
534
androgen blockade adjuvant to radiotherapy, 286
atrophy in prostate needle biopsy, 279
biochemical progression in patients with screen detected, 506
biopsy, 222
blood loss and laparoscopic prostatectomy, 230
clinical stage, 222, 331
cumulative proportion survival and age, 534
dedifferentiation following antiandrogen therapy, 283
diagnosis, 222
digital rectal examination, 222
disease-free survival, 222
disease-free survival and positive fragments, 37
extent of lymphadenectomy for pTXNO PCa, 180
extraperitoneal laparoscopic radical prostatectomy, 228
extra-prostatic extension, prediction, 447
focal prostate carcinoma, 280
free-to-total PSA ratio, 222
functional results and laparoscopic prostatectomy, 230
Gleason score, 222
Gleason score and age, 333, 534
Gleason score on biopsy, 326
hospital stay and laparoscopic prostatectomy, 228
initial PSA and subsequent cancer detection, 222
invasion of seminal vesicle, prediction, 447
laparoscopic radical prostatectomy, 228
localized prostate cancer, 34, 222, 228
needle biopsy, 34, 131, 326, 445
neoplasms staging, 34, 137, 222, 331, 445
neoplasms staging and age, 331
normal digital rectal examination, 437
organ-confined, 328, 437
outcome following anatomical radical prostatectomy, 86, 437
pathological stage, 137, 222, 331, 437, 445
pathological stage and age, 331
pathological extension by Gleason on biopsy, 326
PIN, 131
percentage
of fragments affected in biopsies, 34, 445
perineural invasion and age, 334
positive lymph nodes, 328
positive seminal vesicle, 328
positive surgical margins and age, 534
prediction of pathological stage though percentage of involved fragments,
445
prognosis, 34
prognostic factors, 34
prostate cancer in large prostates, 87
prostate volume and laparoscopic prostatectomy, 229
prostatic neoplasms, 34, 222, 229
prostatic-specific antigen (PSA), 222
PSA adjusted for transition zone volume, 137
PSA distribution in patients with clinical stage T1c, 438
PSA levels and cure perspective, 437
PSA levels and staging, 36
PSA recurrence, 222
radical retropubic prostatectomy, 222, 437
radiotherapy following radical surgery and impact on urinary continence,
408
recurrence-free survival according to PSA in stage T1c, 439
relative risk and positive fragments, 38
repeat prostate biopsy following PIN diagnosis, 131
risk factors of seminal vesicle involvement, 447
surgery vs. external radiation vs. seed implantation, 287
surgical technique, laparoscopic, 228
survival of patients with PCa and normal PSA, 222
screening for, 34, 131, 222
testicular metastasis of, 51
testosterone levels are associated with positive surgical margins,
609
total prostate volume vs. transition zone volume, 140
transition zone, 137
tumor extension and age, 534
ultrasound guided biopsy, 34
Reconstructive
urology
anterior
anastomotic urethroplasty, 319, 459
artificial pathway for bladder control in children with spina bifida,
405
buccal mucosal graft for urethral reconstruction, 406
buccal mucosal grafts placed on the ventral, dorsal or lateral surface
of the urethra, 605
buccal mucosal onlay urethroplasty, 320
complications of synthetic slings, 85
donor-site morbidity in buccal mucosa urethroplasty, 604
drug therapy in female SUI, 176
duloxetine and pelvic exercises for SUI, 175
fasciocutaneous urethroplasty, 319
ileal neobladder in women, 410
laparoscopic assisted cystoprostatectomy and ileal bladder, 362
laparoscopy for treatment of incisional lumbar hernia, 309
Macedo-Malone antegrade continence enema, 173
Monti principle, experimental, 62
polypropylene mesh for incisional lumbar hernia, 311
primary urethral reconstruction, 177
recanalization of ureter by guide-wire puncture, 264
reconstruction after sling erosion in women, 262
reconstruction of penile and scrotal skin, 262
urethroplasty, extended complications, 315
urinary reservoirs, experimental, 62
urinary reservoirs, laparoscopic, 362
ventral buccal mucosal onlay urethroplasty, 459
Renal
neoplasms
age,
12
angiomyolipomas, 269
cancer specific survival, 13
collecting duct carcinoma and oncocytoma, 465
conservative surgery, 100
cryoabaltion, 273
disease-free survival, 13
epithelial neoplasms, 467
kidney carcinoma and XP11.2 /TF3 (ASPL-TFE3) gene, 251
microvascular invasion, 12
necrosis, 12
nephrectomy for, 251
neoplasm metastasis, 10
oncocytoma, 465
partial nephrectomy, 100
prognostic factors in sarcomatoid tumors, 10
recurrence, 12
renal cell carcinoma as a cervical mass, 151
renal pelvis tumor and pseudo-Meg’s syndrome, 256
sarcomatoid renal cell carcinoma, 10
TFE3 protein, 251
thrombus in the inferior vena cava, 49
tumor size, 12
XP11.2 translocation, 251
Renal
transplantation
bench
surgery, 519
cadaveric kidney transplantation, 519
graft survival in children, 558
grafts with multiple arteries, complications, 125
hand-assisted right laparoscopic nephrectomy, 17, 421
in children, 558
living donors, 17, 421
multiple arteries, 519
renal arteries and hand-assisted right laparoscopic nephrectomy,
17
right renal vein elongation with vena cava, 519
Surgical
technique
buccal
mucosal grafts placed on the ventral, dorsal or lateral surface
of the urethra, 605
donor-site morbidity in buccal mucosa urethroplasty, 604
extracorporeal circulation for nephrectomy, 49
transperitoneal laparoscopic nephrectomy in inflammatory disease,
25
for nephrectomy with thrombus in the inferior vena cava, 49
grafts with multiple arteries, complications, 125
hand-assisted right laparoscopic nephrectomy, 17
hand-assisted laparoscopic nephrectomy in large kidneys, 526
indications for percutaneous nephrostomy for patients with obstruction,
117
laparoscopic assisted cystoprostatectomy and ileal bladder, 362
laparoscopic extraperitoneal prostatectomy, 228
laparoscopic nephrectomy in inflammatory disease, 22
laparoscopic ureteral reimplantation, 51
laparoscopy for treatment of incisional lumbar hernia, 309
Monti principle for continent gastrostomy, 62
partial laparoscopic nephrectomy, 100
retroperitoneal laparoscopic nephrectomy in inflammatory disease,
25
retroperitoneal laparoscopic partial nephrectomy in cancer, 102
retroperitoneoscopy for renal and ureteral stones, 111
right renal vein elongation with vena cava, 519
simplified upper pole nephrectomy in children, 157
stents for urethral stricture, 552
transluminal puncture in complete ureteral obstruction, 264
transperitoneal laparoscopic partial nephrectomy in cancer, 102
vascular technique for renal grafts with multiple arteries, 125
Y-shaped orthotopic ileal bladder by laparoscopy, 362
Testis,
Adnexas and Scrotum
abnormalities,
57
apoptosis and proliferation in human undescended testes, 404
benign neoplasms, 359
biopsy for predicting spermatozoa for ICSI, 338
collagen analysis in cryptorchidism, 562
conservative surgery for benign tumor, 359
cryptorchidism, 57
fetus, 57
hCG vs. collagen and seminiferous analysis in cryptorchidism, 562
hematocele of vaginal sac, 555
inguinal hernia, 57
MRI for differential diagnosis of scrotal mass, 555
non-obstructive azoospermia, 338
pre-pubertal dermoid cyst, 359
processus vaginalis and age, 57
scrotal ultrasonography, 555
seminiferous tubules in cryptorchidism, 562
sperm collection by testicular biopsy, 338
testicular histopathology predictive of ICSI, 338
testicular metastasis of prostate cancer, 54
testicular volume and infertility, 236
varicocele-associated infertility, 236
volume in non-obstructive azoospermia, 44
Tissue
engineering and reconstructive urology
cell-seeded
acellular matrix, 199
extracellular matrix grafts, 192
intestinal mucosa, 192
small intestine, 192
vascularized scaffold for artificial tissue and organ generation,
284
Trauma
arterial
embolization in patients with blunt polytrauma, 499
conservative management of abdominal gunshot wounds, 169
degloving of penile and scrotal skin, 262
expectant management of renal trauma, 596
erectile dysfunction after long-distance cycling event, 497
life-threatening pelvic hemorrhage after transcatheter arterial
embolization, 598
management of penile fracture, 398
outcome after major renovascular injuries, 79
pelvic fracture-related urethral trauma, 399
posterior urethral disruption, 276
renovascular injury - renal preservation, 78
spinal cord trauma and infertility, 377
transpelvic gunshot wounds, 170
traumatic ureteral injuries, 277
traumatic uretero-vaginal fistula, 264
ureteral lesions, 264
ureteral stenosis after laparoscopic gynecologic surgery, 51
urethral stricture, 315
Ureter
abnormalities,
157, 549
calculous in orthotopic ureterocele, 549
complete ureteral obstruction and puncture, 264
congenital abnormalities, 356
ectopic ureter, 157
extrinsic obstruction with indwelling stent, 431
intrinsic ureteral obstruction, 431
laparoscopic ureteral reimplantation, 51
orthotopic ureterocele, 549
retrocaval ureter, 147
retrograde double-J stenting, 431
ureteral obstruction, 117, 431
ureteral replacement, 198
ureteral replantation, 356
ureteral stent, 431
ureteral stricture, 51
ureterocele, 157
Urethra
abnormalities,
259
angiomyxoma mimicking urethral tumor, 475
anterior anastomotic urethroplasty, 319, 459
artificial sphincter for recurrent stenosis treated with stent,
552
buccal mucosal grafts placed on the ventral, dorsal or lateral surface
of the urethra, 605
buccal mucosal onlay urethroplasty, 320
donor-site morbidity in buccal mucosa urethroplasty, 604
early catheter removal after urethroplasty, 459
fasciocutaneous urethroplasty, 319
fibroepithelial polyp, 155
hypospadias repair, tissue engineering, 196
partial urethral duplication in human, 259
posterior anastomotic urethroplasty, 319
recurrent vesico-urethral anastomosis, 552
stents for urethral stricture, 552
urethral neoplasms, 155
urethral stricture, 315, 459
urethral stricture after radical prostatectomy, 552
urethroplasty, acellular matrix grafts, 197
urethroplasty, extended complications, 315
ventral buccal mucosal onlay urethroplasty, 459
Voiding
dysfunction, see also incontinence
bladder
filling with hypertonic and hypotonic solutions, 569
completely dry rate: a critical re-evaluation of the outcomes of
slings, 612
cystometry in rats, 579
cystoscopy with hydrodistension for interstitial cystitis, 508
darifenacin in the management of urinary urgency, 181
effect of fluid intake on urinary symptoms in women, 610
overactive bladder, 569
Portuguese version of ICIQ-SF, 482
pubovaginal sling - small intestinal submucosa, 196
sacral neuromodulation, 509
solifenacim antimuscarinic agent in overactive bladder, 89
structural alterations of the bladder caused by instability, 579
urodynamics, 569 |